Immunovant, Inc. (IMVT)

NASDAQ:IMVT

IMVT

Immunovant

RESEARCH TOOLSreports

Want to see IMVT full AI Analyst Report?

Compare Immunovant (IMVT) vs. Competitors

951 Followers

Comparison Results

IMVT

Immunovant

$29.30

$6.84B

-13.24

121.28%

10 Buy

3 Hold

0 Sell

Strong Buy

Protagonist Therapeutics

$105.98

$6.40B

-53.86

99.96%

10 Buy

1 Hold

0 Sell

Strong Buy

Crinetics Pharmaceuticals

$41.00

$3.75B

-7.24

13.14%

8 Buy

0 Hold

0 Sell

Strong Buy

Mirum Pharmaceuticals

$97.95

$6.19B

-7.10

116.67%

13 Buy

0 Hold

0 Sell

Strong Buy

Kymera Therapeutics

$87.71

$6.70B

-24.29

164.74%

12 Buy

0 Hold

0 Sell

Strong Buy

MoonLake Immunotherapeutics

$18.34

$1.41B

-5.22

-51.76%

9 Buy

1 Hold

2 Sell

Moderate Buy

xxxxxxxxxxxxx

IMVT vs MLTX

xxxxxxxxxxxxx

Performance Comparison

IMVT

Immunovant

32.86

17.45

113.24%

PTGX

Protagonist Therapeutics

94.92

44.77

89.27%

CRNX

Crinetics Pharmaceuticals

34.52

2.64

8.28%

MIRM

Mirum Pharmaceuticals

96.33

50.36

109.55%

KYMR

Kymera Therapeutics

78.47

35.34

81.94%

MLTX

MoonLake Immunotherapeutics

18.82

-22.34

-54.28%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >